Buparlisib in Melanoma Patients Suffering From Brain Metastases (BUMPER)
Clinical trial NCT02452294 · UNKNOWN
Trial details
- NCT number
- NCT02452294
- Sponsor
- University Hospital Tuebingen
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-01
- Primary completion
- 2017-12-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.